<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03530826</url>
  </required_header>
  <id_info>
    <org_study_id>All4Cure01</org_study_id>
    <nct_id>NCT03530826</nct_id>
  </id_info>
  <brief_title>A Crowd Sourcing Platform for Patients With Cancer</brief_title>
  <official_title>A Crowd Sourcing Platform for Patients With Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>All4Cure</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>All4Cure</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      All4Cure aims to accelerate learning about cancer by sharing medical information and research
      results from cancer patients with fellow cancer patients, oncologists, and scientists on the
      All4Cure website with the hope that together patients, clinicians and researchers can cure
      cancer faster.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The core hypothesis tested by this study is that engaging researchers, clinicians and
      patients in an online knowledge sharing platform will enable patients to better understand
      cancer, better inform treatment decisions made by oncologists and accelerate cancer research.
      Leftover samples from patients with cancer (blood, bodily fluids and/or tissues collected for
      clinical purposes) will be obtained and sent for various types of analyses and results will
      be shared on the All4Cure website.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 26, 2018</start_date>
  <completion_date type="Anticipated">January 31, 2028</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2028</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Change in tumor tissue molecular profiles</measure>
    <time_frame>6 years</time_frame>
    <description>Profiles of pre- and post-treatment tumor tissue will be compared.</description>
  </primary_outcome>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Cancer</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>No Intervention</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult cancer patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Have been diagnosed with cancer.

          -  Be under the care of a physician.

          -  Be 18 years of age or older.

          -  Be able to read English at an 8th grade level or higher.

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carl A Blau, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>All4Cure</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Carl A Blau, MD</last_name>
    <phone>2064121787</phone>
    <email>tony@all4cure.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kimberly A Burton, PhD</last_name>
    <phone>2069482711</phone>
    <email>kaburton@all4cure.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>All4Cure</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carl A Blau, MD</last_name>
      <phone>206-412-1787</phone>
      <email>tony@all4cure.com</email>
    </contact>
    <contact_backup>
      <last_name>Kimberly A Burton, PhD</last_name>
      <phone>2069482711</phone>
      <email>kaburton@all4cure.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 7, 2018</study_first_submitted>
  <study_first_submitted_qc>May 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2018</study_first_posted>
  <last_update_submitted>May 18, 2018</last_update_submitted>
  <last_update_submitted_qc>May 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>All4Cure</investigator_affiliation>
    <investigator_full_name>Carl Anthony Blau, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>nonidentifiable clinical and research data may be shared with other researchers.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

